Lifecore Biomedical, Inc. LFCR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Lifecore Biomedical, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s current ratio?
- Lifecore Biomedical, Inc. (LFCR) reported current ratio of 3.8× in Q1 2026.
- How has Lifecore Biomedical, Inc.'s current ratio changed year-over-year?
- Lifecore Biomedical, Inc.'s current ratio increased by 33.4% year-over-year, from 2.8× to 3.8×.
- What is the long-term trend for Lifecore Biomedical, Inc.'s current ratio?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s current ratio has grown at a 21.6% compound annual growth rate (CAGR), from 1.4× to 3.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.